Omega-3 Derivative Resolvin D3 Blocks CGRP-Driven Itch and Inflammation in Psoriasis
Resolvin D3, an omega-3-derived lipid, reversed psoriasis-like itch and skin inflammation in mice by blocking TRPV1 channels and reducing CGRP in sensory neurons — and also worked on human neurons.
Quick Facts
What This Study Found
Resolvin D3 reversed psoriasiform itch and prevented skin inflammation by inhibiting TRPV1 and reducing CGRP in sensory neurons, with confirmed activity in human DRG neurons.
Key Numbers
2.8 mg/kg single dose reversed itch; repeated dosing prevented itch + inflammation; reduced CGRP; CGRP knockdown replicated effects; confirmed in human DRG neurons
How They Did This
Mouse imiquimod psoriasis model with behavioral testing, DRG neuron electrophysiology, CGRP knockdown, and translational validation in human DRG neurons. RvD3 administered systemically at 2.8 mg/kg.
Why This Research Matters
Current psoriasis biologics are expensive and have side effects. A naturally derived molecule that simultaneously addresses both itch and inflammation through neuronal pathways could offer a safer alternative.
The Bigger Picture
Resolvins are part of the body's natural inflammation-resolution system. This study connects omega-3 metabolism to the CGRP pathway — the same pathway targeted by migraine drugs — opening new possibilities for treating inflammatory skin diseases.
What This Study Doesn't Tell Us
Mouse model (imiquimod) doesn't perfectly replicate human psoriasis; human data limited to isolated neurons, not clinical psoriasis patients; long-term dosing effects unknown.
Questions This Raises
- ?Would resolvin D3 be effective in human psoriasis clinical trials?
- ?Could omega-3 supplementation increase endogenous resolvin D3 levels enough to help psoriasis?
- ?How does RvD3 compare to CGRP-blocking antibodies already used for migraine?
Trust & Context
- Key Stat:
- Single dose reversed itch One systemic injection of RvD3 at 2.8 mg/kg reversed established psoriasiform itch in mice
- Evidence Grade:
- Moderate — strong mechanistic animal data with human neuron validation, but no clinical trial in psoriasis patients.
- Study Age:
- Published in 2020; resolvin and CGRP research have both advanced significantly since.
- Original Title:
- Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.
- Published In:
- Theranostics, 10(26), 12111-12126 (2020)
- Authors:
- Lee, Sang Hoon, Tonello, Raquel, Im, Sang-Taek(2), Jeon, Hawon, Park, Jeongsu, Ford, Zachary, Davidson, Steve, Kim, Yong Ho, Park, Chul-Kyu, Berta, Temugin
- Database ID:
- RPEP-04936
Evidence Hierarchy
Frequently Asked Questions
What is resolvin D3?
A natural anti-inflammatory molecule your body makes from omega-3 fatty acids (DHA). It helps resolve inflammation rather than just suppressing it.
Could fish oil supplements help psoriasis through this mechanism?
Theoretically, more omega-3 could mean more resolvins, but dietary supplements likely don't produce the concentrated levels used in this study. Direct resolvin therapy would be more targeted.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04936APA
Lee, Sang Hoon; Tonello, Raquel; Im, Sang-Taek; Jeon, Hawon; Park, Jeongsu; Ford, Zachary; Davidson, Steve; Kim, Yong Ho; Park, Chul-Kyu; Berta, Temugin. (2020). Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.. Theranostics, 10(26), 12111-12126. https://doi.org/10.7150/thno.52135
MLA
Lee, Sang Hoon, et al. "Resolvin D3 controls mouse and human TRPV1-positive neurons and preclinical progression of psoriasis.." Theranostics, 2020. https://doi.org/10.7150/thno.52135
RethinkPeptides
RethinkPeptides Research Database. "Resolvin D3 controls mouse and human TRPV1-positive neurons ..." RPEP-04936. Retrieved from https://rethinkpeptides.com/research/lee-2020-resolvin-d3-controls-mouse
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.